Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Testing of efficacy of photodynamic therapy with a new photosensitizer - a of chlorin e6 derivative (BLC 1010)

Not Accessible

Your library or personal account may give you access

Abstract

Efficacy of PDT with new chlorin e6 photosensitizer (BLC 1010) has been tested in 72 cancer patients. 44 patients (61 %) achieved a complete response and 39 % of the patients a partial response (28 patients, including 15 patients treated for palliation).

Rapid elimination of BLC 1010 from the organism solves the problem of skin phototoxicity encountered in PDT up to now. This property together with its high tumor to normal ratio makes it a promising photosensitizer for PDT. Further advantage is that portable diode lasers with proper wavelength are available.

© 2001 OSA/SPIE

PDF Article
More Like This
Five Years Experience of Photodynamic Therapy with New Chlorin Photosensitizer

Valery A. Privalov, Elena V. Kochneva, and Alexander V. Lappa
TuD4 European Conference on Biomedical Optics (ECBO) 2005

Photodynamic diagnostics and therapy of premalignant lesions and cancer – own three year clinical experience

Aleksander Sieron, Mariusz Adamek, Tomasz Biniszkiewicz, Wojciech Cebula, Grzegorz Cieslar, Aleksandra Kawczyk - Krupka, Grzegorz Niepsuj, Michał Szygula, Boguslaw Wojciechowski, and Witold Zieleznik
4433_120 European Conference on Biomedical Optics (ECBO) 2001

Photodynamic therapy of non melanoma skin cancer murine model by topical application of a novel mTHPC liposomal formulation

E. Alexandratou, M. Kyriazi, T. Trebst, S. Gräfe, and D. Yova
6632_19 European Conference on Biomedical Optics (ECBO) 2007

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.